Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Rating of "Hold" from Analysts

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) has been assigned an average recommendation of "Hold" from the seventeen brokerages that are presently covering the stock, MarketBeat.com reports. Eleven investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $9.7969.

A number of brokerages have recently commented on TDOC. Truist Financial lowered their price objective on Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research report on Tuesday, May 27th. Mizuho began coverage on Teladoc Health in a research report on Friday, July 25th. They set a "neutral" rating and a $10.00 price objective for the company. Evercore ISI boosted their price objective on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 9th. Finally, Bank of America lowered their price objective on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research report on Wednesday, May 28th.

Teladoc Health Stock Up 0.2%

Shares of NYSE:TDOC opened at $7.84 on Tuesday. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58. The firm has a market capitalization of $1.38 billion, a PE ratio of -6.58 and a beta of 1.84. The firm's 50-day moving average is $7.76 and its two-hundred day moving average is $7.76. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. The company had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The business's revenue for the quarter was down 1.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. Analysts predict that Teladoc Health will post -1.16 EPS for the current year.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently made changes to their positions in TDOC. Point72 Asset Management L.P. boosted its holdings in Teladoc Health by 33.6% in the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after purchasing an additional 2,813,568 shares in the last quarter. Two Sigma Investments LP acquired a new position in Teladoc Health in the fourth quarter valued at approximately $18,348,000. Two Sigma Advisers LP boosted its holdings in Teladoc Health by 213.0% in the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock valued at $20,532,000 after purchasing an additional 1,537,094 shares in the last quarter. Nuveen LLC acquired a new position in Teladoc Health in the first quarter valued at approximately $11,789,000. Finally, Vanguard Group Inc. boosted its holdings in Teladoc Health by 7.0% in the first quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider's stock valued at $157,229,000 after purchasing an additional 1,289,183 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.